The Human Metapneumovirus (HMPV) virus strikingly akin to COVID-19, has gained attention amid a surge in cases, particularly in children under 14 in northern China provinces this winter.
Thank you for reading this post, don't forget to subscribe!The outbreak came a few years after the world was first alerted to the emergence of a novel coronavirus in Wuhan, China, which later turned into a global pandemic with over 7 million deaths reported.
Reliable sources have it that health authorities are implementing emergency measures to track and manage the spread with Beijing downplaying the developments as an annual winter occurrence.
Last week on Friday the China’s foreign Ministry spokesperson Mao Ning said that the Respiratory infections often peak during the winter season, showing no worrying situation over the human Metapneumovirus.
Reports coming in show that in the Southern largest city of India Bengaluru at Baptist Hospital, a prominent private healthcare facility in the northern part of the city an eight-month-old baby tested positive for the virus.
The country’s state health department clarified that the sample was not tested in its own labs but emphasized its confidence in the accuracy of the private hospital’s findings.
What is HMPV?
Human metapneumovirus, or HMPV, is a respiratory virus that causes symptoms akin to the common cold and influenza.
While the illness is typically mild, it can lead to severe complications like pneumonia, particularly in infants, the elderly, and those with weakened immune systems.
Metapneumovirus was first identified in the early years in 2000 as a single-stranded RNA virus that spreads through respiratory droplets or contact with contaminated surfaces.
Its symptoms include cough, fever, nasal congestion, and fatigue, with an incubation period of three to six days and unlike Covid-19, there is no vaccine or specific antiviral treatment for HMPV; treatment primarily involves managing symptoms.
About the Author
